## EXC: Exelon Corporation - XLU: Utilities

### Executive Summary

No thesis match: MRS_20 -6.2% below STRENGTH zone (4.0-10.0%); PEG 1.99 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($42.01)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 2)

**1. EXC SEC Filings - Exelon 10-K, 10-Q, 8-K Forms**
- Source: Stock Titan | 20251204T111154 | Neutral | Relevance: 100%
- This article is a dedicated resource for investors and traders to access Exelon (EXC) SEC filings, including annual reports (10-K), quarterly earnings (10-Q), material events (8-K), and insider trading forms (Form 4). It highlights how Stock Titanâ€™s AI-powered analysis simplifies these complex documents, providing real-time alerts and summarized insights. The page also lists recent significant filings, such as insider transactions by William P. Bowers and Bryan Segedi, and a Q2 2025 earnings report.

**2. Exelon Corp. stock underperforms Wednesday when compared to competitors**
- Source: MarketWatch | 20251203T165100 | Bearish | Relevance: 100%
- Exelon Corp. (EXC) stock declined by 1.02% on Wednesday, closing at $44.54, despite a positive trading session for the broader market. This marked the third consecutive day of losses for the company's shares. In contrast, the S&P 500 Index rose 0.30%, and the Dow Jones Industrial Average gained 0.86%.

**3. Is Exelon Stock Underperforming the Nasdaq?**
- Source: Barchart.com | 20251205T133621 | Somewhat-Bullish | Relevance: 100%
- Exelon (EXC) stock has underperformed the Nasdaq Composite ($NASX) over the past three months, year-to-date, and 52-week periods, despite reporting strong Q3 2025 results and reaffirming its full-year guidance. While Exelon excels in the utility sector, its growth has not kept pace with the broader tech-heavy index. Analysts, however, remain moderately optimistic, giving EXC a "Moderate Buy" rating with a price target suggesting a 13.9% premium.

**4. Exelon Corporation $EXC Shares Purchased by Invesco Ltd.**
- Source: MarketBeat | 20251204T124539 | Somewhat-Bullish | Relevance: 100%
- Invesco Ltd. increased its stake in Exelon Corporation by 7.4% in the second quarter, now owning 14,826,137 shares valued at $643,751,000. Several other institutional investors also adjusted their positions, with institutional investors collectively owning 80.92% of the company's stock. Exelon recently announced a quarterly dividend of $0.40 per share, yielding 3.6%, and reported strong quarterly earnings beating analyst estimates.

**5. Exelon Breaks Below 200-Day Moving Average - Notable for EXC**
- Source: Nasdaq | 20251204T111154 | Somewhat-Bearish | Relevance: 100%
- Shares of Exelon Corp (EXC) fell below their 200-day moving average of $44.66, trading as low as $44.22 on Wednesday, December 3, 2025. The stock was down approximately 1% on the day, with its 52-week range being $35.94 to $48.505. This marks a notable technical event for investors following energy stocks.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.36M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.4% (+0.4%)
- Blackrock Inc.: 11.6% (-1.4%)
- State Street Corpora: 6.6% (-0.0%)
- Geode Capital Manage: 2.9% (+1.8%)
- FMR, LLC: 2.8% (+7.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.7% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.99 elevated, pricing in significant growth expectations. Forward P/E 15.4x stretched relative to 5% growth. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $44.0B |
| Beta | 0.55 |
| 52W Range | $37.06 - $48.51 |
| Short Interest | 5.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.99 |
| Forward P/E | 15.4 |
| Current P/E | 16.2 |
| YoY Growth | 5.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.5% to -6.2% (-4.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 10.2pp (needs >4.0% for momentum thesis). AM_20 at -4.0% indicates price below own 20MA trend. Below SMA200 (0.98x), long-term trend not supportive. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -6.17% (CS: 7) | Weak |
| RSI_14 | 35.5 | Neutral |
| MACD Histogram | -0.24 | Bearish |
| vs SMA20 | 0.960x | Below |
| vs SMA50 | 0.947x | Below |
| vs SMA200 | 0.981x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $43.81
- **Stop Loss:** $42.01 (4.1% risk)
- **Target:** $45.61 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 166
- **Position Value:** $7,272.46
- **Portfolio %:** 7.27%
- **Risk Dollars:** $300.00
- **Risk Per Trade:** 0.30%
- **Modifiers:** L1 100% | L2 25% | Combined 0.30x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TOXIC (Zone G) | 0.25x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-11 (Est: $0.58)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.78 | $0.86 | +10.5% |
| 2025Q2 | $0.37 | $0.39 | +6.1% |
| 2025Q1 | $0.86 | $0.92 | +6.9% |
| 2024Q4 | $0.59 | $0.64 | +8.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*